Ipsen (France)
Ipsen is a French biopharmaceutical company headquartered in Paris, France, with a focus on drug development and commercialization in three therapeutic areas: oncology, rare diseases and neuroscience. Ipsen is one of the world's top 15 biopharmaceutical companies in terms of oncology sales. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Ipsen (France), France, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
49%
Total
Publications
1.9K
Total Open
Publications
943
Total
Citations
39K
Open Access
Percentage
49%
Total
Publications
1.9K
Total Open
Publications
943
Total
Citations
39K
Breakdown
Publisher Open
23%
Both
23%
Other Platform Open
3%
Closed
51%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 30%
261
Hybrid 53%
460
No Guarantees 17%
148
Other Platform Open
Domain 73%
365
Institution 41%
203
Other Internet 19%
96
Public 3%
17
Preprint 0%
2
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 370 |
DOI | Other Internet | 78 |
Le Centre pour la Communication Scientifique Directe - HAL - Diderot | Institution | 43 |
Europe PMC | Domain | 33 |
Unknown Repository | Other Internet | 22 |
Elsevier - Scopus | Institution | 21 |
DANS - Data Archiving and Networked Services | Institution | 19 |
Digital Access to Libraries | Institution | 15 |
Figshare | Public | 14 |
Konstfack University of Arts, Crafts, and Design - Publications | Institution | 12 |